Circulating leukocytes are important in dissemination of cytomegalovirus (CMV) infection in humans. In the mouse model of murine CMV infection (MCMV), it has been shown that infection peaks on days 5 to 7 after experimental infection, when 0.01 to 0.1% of the circulating leukocytes contain viral DNA. In our laboratory, MCMV DNA was detected by in situ hybridization predominantly in the mononuclear cells on day 6 after acute infection. Infectious virus was recovered from day 6 mononuclear fractions in 16 of 16 mice compared with that from day 6 polymorphonuclear fractions in 4 of 16 mice. An eclipse phenomenon was noted in the blood leukocytes by quantitative blot hybridization: the amount of MCMV DNA present was small on day 2, diminished on days 3 and 4, and then increased markedly on days 5 and 6 in both the mononuclear and polymorphonuclear fractions immediately following viral augmentation in the liver and spleen. MCMV immediate-early and glycoprotein B (late) transcripts were present in pooled mononuclear fractions only on day 6 of acute infection but not in pooled polymorphonuclear fractions. Collectively, these data demonstrate that (i) circulating leukocytes, predominantly mononuclear, are involved in dissemination of MCMV; (ii) a primary viremia with dissemination of MCMV to reticuloendothelial organs (liver and spleen) occurs and is followed by viral amplification and a subsequent, more intense secondary viremia; and (iii) immediate-early viral mRNA and glycoprotein B mRNA transcripts are detectable only during peak infection on day 6 in mononuclear leukocytes but not in polymorphonuclear leukocytes.
Human cytomegalovirus (CMV) may frequently be recovered from the peripheral blood leukocytes of patients with disseminated infection (5, 9, 15, 33) , and molecular studies have confirmed that human CMV infects the circulating leukocytes in humans (6, 10, 20, 26, 30) . Murine CMV (MCMV) infection has been an excellent experimental model to study the interaction of CMV and various tissues or cells, including leukocytes (2, 14, 16, 23) . There are numerous reports detailing the sequence and histopathologic consequences of organ involvement during acute MCMV infection of mice (14) ; however, little information is available concerning specific virus-cell interactions which occur during viremic dissemination prior to the infection of organs and establishment of viral latency. Mice infected with MCMV develop hematologic manifestations similar to those of human disease (2, 23) . Bale and O'Neil (1) have demonstrated by in situ hybridization that viral DNA is present in 0.001 to 0.1% of circulating leukocytes in mice between days 5 to 7 after intraperitoneal inoculation of MCMV. When MCMV DNA-positive cells could be identified, they were usually mononuclear cells, possibly monocytes. MCMV could be recovered from unfractionated leukocytes of mice for approximately 3 weeks and was closely correlated with the detection of intracellular viral DNA. Experiments to determine whether MCMV was replicating in blood leukocytes were not performed. Here, we present our molecular analysis of acute MCMV viremia in mice. The results indicate that the viremia is quantitatively biphasic and that MCMV replication may be occurring in mononuclear cells.
MATERIALS AND METHODS
MCMV stocks. MCMV (Smith strain) was maintained by serial passage in mice. Virus stocks were prepared from 10% salivary gland homogenates of mice infected 2 to 3 weeks earlier by intraperitoneal inoculation of 105 PFU of MCMV (17, 18) .
Homogenates were prepared in Eagle's minimal essential medium and stored at -70°C after the addition of dimethyl sulfoxide at a 10% concentration. Quantitative assays of infectious virus were performed in secondary mouse embryo cells under overlay with 0.2% agarose. Assay cultures were maintained at 37°C for 5 days and then stained with crystal violet for enumeration of plaques under a dissecting microscope.
Infection of mice. Female BALB/c mice obtained from the National Cancer Institute (Bethesda, Md.) were used in all experiments. Animals were inoculated with virus at 7 weeks of age. The mice were injected intraperitoneally with a sublethal dose (105 PFU) of Smith strain MCMV.
Separation of leukocyte populations. Animals were sacrificed at various times. Blood was obtained by cardiac puncture and separated into mononuclear and polymorphonuclear fractions by using a Ficoll-Hypaque gradient (28) .
Culture of peripheral blood leukocytes. -CCA-GAC-TCT-CTT-TTC-TGA-GGG-CCC-TAG- ATT-3' (19 (25) (25) .
MCMV mRNA was transcribed to cDNA with 200 U of Moloney murine leukemia virus reverse transcriptase (Gibco-BRL) according to the manufacturer's instructions, with 1 jig of the total RNA as a template. The 3' primer (10 pmol) for the glycoprotein B mRNA transcript was primer 1138. MCMV cDNA generated by reverse transcription was amplified by a nested PCR. Each primary reaction mixture contained 10 mM Tris-HCl (pH 8.4), 50 mM potassium chloride, 1.5 mM magnesium chloride, 0.5 jiM (each) primers 1137 and 1138, 200 jiM (each) deoxynucleoside triphosphates, and 2.5 U of Taq DNA polymerase in a volume of 0.1 ml. Samples were overlaid with mineral oil and amplified in a DNA thermal cycler (Perkin-Elmer Cetus) for 30 cycles as follows: denaturation at 94°C for 1 min, annealing of extension primers at 55°C for 1.5 min, and primer extension at 72°C for 2 min followed by a 10-minute final extension at 72°C.
For the secondary amplification, 5 jil of the primary amplification product of each sample was added to a tube with 8 of water and 87 ,lI of a reaction mixture containing 2.5 pl of the 3' internal primer (1140), 2.5 RI of the 5' internal primer (1139), 0.5 pl of Taq DNA polymerase, 1.5 RI of each deoxynucleoside triphosphate, and 80 pl of lx PCR buffer (containing 1.5 mM MgCl2) overlaid with mineral oil. Each sample was then cycled an additional 30 times as described above. The nested reverse transcriptase PCR was performed on each sample with and without DNase incubation as described previously to detect the 408-bp PCR product amplified from cDNA of glycoprotein B mRNA. In addition, samples to be tested for the presence of MCMV RNA were studied with and without the addition of reverse transcriptase to verify that cDNA derived from the transcript and not viral genomic DNA had been detected.
Nested samples were analyzed as described above for the immediate-early gene 1 samples with electrophoresis, transfer to a nylon membrane, and Southern hybridization followed by autoradiography. A 21-bp oligonucleotide complementary to a sequence lying between the internal primer pairs was used as the probe. The base sequence of the probe is (bases 2796 to 2816) 5'-GCG-GCA-GTG-ACG-ATT-CGG-GTA-3' (25) .
Physically separate pre-and post-PCR stations were used, and barrier tip pipettes and aliquots of premixed PCR reagents were employed throughout. In each amplification experiment, positive control samples included total RNA extracted from mouse embryo fibroblasts infected with MCMV and total RNA extracted from the spleen of a mouse with acute MCMV infection. Negative controls, which were randomly interspersed among the samples, included total RNA extracted from uninfected mouse embryo fibroblasts and total RNA extracted from pooled polymononuclear and mononuclear leukocyte fractions of uninfected mice. To quantify the amount of viral DNA present in mononuclear and polymorphonuclear leukocytes from initial infection until peak infection, blot hybridization with videodensitometry was utilized. Seven-week-old BALB/c mice were injected intraperitoneally with MCMV as described above. On days 1 to 6 of acute infection, four mice were sacrificed, and pooled blood, spleens, livers, and salivary glands were obtained.
RESULTS
Pooled leukocyte specimens were also collected from uninfected animals to serve as negative controls. Serial dilutions of known quantities of purified MCMV DNA were used as standards. Relatively small amounts of MCMV DNA were detected in both leukocyte populations on days 2 and 3 after infection (Fig. 2) . Viral DNA disappeared completely on day 4 in the granulocytes and declined markedly in the mononuclear cells as well. Subsequently, a much more intense secondary viremia recurred in both cell types on day 5, and the amount of MCMV DNA in mononuclear cells exceeded that in the neutrophils on day 6 . During peak infection on day 6, 684 pg of MCMV DNA per 10 ,ug of cellular DNA was detected in mononuclear leukocytes, which corresponds to approximately 170 viral genomic equivalents per 100 cells. To determine whether the secondary viremia resulted from amplification of MCMV infection in the reticuloendothelial system, the amount of viral DNA also was quantified in the spleen and liver. MCMV DNA first appeared in the spleen on day 3 following infection, and large amounts were found in both the spleen and liver on day 4, at a time when leukocytes contained little viral DNA and just prior to the more intense secondary viremia (Fig. 2) Ten mice were sacrificed on day 6 of acute infection with MCMV. RNA was extracted from the pooled blood leukocyte fractions for studies to detect the late transcript glycoprotein B. Total RNA extract samples of both mononuclear and polymorphonuclear leukocytes, with and without DNase I treatment, were used in nested enzymatic amplification experiments with and without the addition of reverse transcriptase. As shown in Fig. 4 , the appropriate 408-bp cDNA product was detected in RNA extracted from mononuclear cells on day 6 after acute infection and treated with DNase I but not in the polymorphonuclear leukocytes. No cDNA was detected in samples in which reverse transcriptase was omitted from the reaction mixture.
DISCUSSION
In previous studies of viremia during acute MCMV infection of mice using quantitative assays of viral infectivity, extremely small numbers of cells have been found to carry the infectious virus (2. 32). In addition, mononuclear cells have been the main cell types involved. In the first molecular analysis of MCMV viremia, Bale and O'Neil (1) found that infection of leukocytes peaked on days 5 and 7 after inoculation of the virus, although the frequency of cellular infection reached only 0.01 to 0.1% of leukocytes. Our results are in accord with this level of quantitation and also support the initial observation in unfractioned leukocytes that mononuclear cells are primarily involved in dissemination of infection. Thus, infectious MCMV could be recovered from the mononuclear cells of all animals (16 of 16) at the time of peak viremia on day 6 and from only 4 of 16 polymorphonuclear cell preparations from the same animals. In addition, viral DNA could be detected consistently in a small percentage of mononuclear cells by in situ hybridization but only rarely in polymorphonuclear cells. Finally, the amount of MCMV DNA detected by quantitative blot hybridization was much higher in mononuclear cells on day 6 after infection than in the polymorphonuclear cells. At times, however, significant amounts of viral DNA were detected by the blot hybridization assay in the polymorphonuclear cells despite negative results by in situ hybridization and by viral culture. This apparent discrepancy could have resulted from the use of a much smaller oligonucleotide probe in the in situ hybridization assays compared with the larger (32-kb) subgenomic EcoRI fragment used for blot hybridization. This explanation seems unlikely, however, because Bale and O'Neil used the 34-kb HindIII A fragment in their in situ hybridization experiments and were unable to detect MCMV DNA in polymorphonuclear cells. Another possibility is that viral DNA was present in large amounts in a very rare polymorphonuclear cell (or in contaminating mononuclear cells) that was not detected by in situ hybridization. Finally, phagocytic degradation of MCMV DNA could have occurred in the polymorphonuclear cells, resulting in inactivation of infectious virus but persistence of DNA fragments that were detected only by the larger subgenomic probe. In summary, our results do not exclude the possibility that neutrophils play some, albeit minor, role in MCMV viremia. A previously unrecognized biphasic aspect of MCMV viremia was clearly documented in these experiments. By a quantitative DNA blot hybridization assay, no MCMV DNA was detected in either mononuclear or polymorphonuclear cells 24 h after intraperitoneal infection. Forty-eight hours after infection, viral DNA was detected in both cell populations, when the amount of MCMV DNA in mononuclear cells was approximately twice that in the granulocytes. On the third and fourth days after infection, the amount of MCMV DNA declined markedly in both cell types and disappeared completely in the polymorphonuclear cells on day 4. On day 5, however, viral DNA returned in both cell populations at a high level and increased even further during peak infection on day 6, especially in the mononuclear cells. This more intense secondary viremia clearly followed the detection of MCMV infection in the spleen on day 3 and a marked amplification of viral DNA in both the spleen and liver on day 4. The findings are consistent with the interpretation that the secondary viremia resulted from replication and release of infectious virus from cells within these reticuloendothelial organs and recall Fenner's classic experiments in animals infected with infectious ectromelia virus of mice (mouse pox virus) (7, 8) . In the latter experiments, inoculation of mouse pox virus into the footpad or ear skin of mice was followed by spread to the regional lymph nodes (2, 17, 21, 29) .
In some respects, cytomegalovirus viremia in mice is similar to that in humans although there are some significant differences, perhaps attributable to the predominance of mononuclear leukocytes in the peripheral blood of mice. Quantitatively, the amount of viral DNA within leukocytes is surprisingly similar although in humans polymorphonuclear cells contain significantly greater amounts than do mononuclear cells (26) . Thus, the median amounts of viral DNA in granulocytes and mononuclear cells in our studies of patients with AIDS who had visceral organ disease due to CMV were 632 and 325 pg per 10 ,ug of cellular DNA, respectively (27) . In addition, in virtually all studies of human CMV viremia, the virus is much more frequently recovered from granulocytes than from mononuclear cells (5, 15, 26) , although both cell types are clearly involved in viral dissemination (6, 10, 11, 31) . With regard to viral gene expression, both the immediate-early genes and an early gene (pp65) appear to be expressed in polymorphonuclear cells during viremic dissemination in humans (6, 31) . Whether late genes are expressed in infected granulocytes has not been resolved definitively, but it appears unlikely. In mononuclear cells of humans with CMV viremia, recent studies indicate that the immediate-early genes are virtually always expressed and that late genes may also be transcribed in some patients (10, 22) . Whether, as in the mouse, there are quantitative factors which relate to CMV gene expression in either cell type remains to be determined in humans.
